Australia markets closed

Q32 Bio Inc. (QTTB)

NasdaqGM - NasdaqGM Delayed price. Currency in USD
Add to watchlist
17.33-0.72 (-3.99%)
At close: 04:00PM EDT
Currency in USD

Valuation measures4

Market cap (intra-day) 206.96M
Enterprise value 91.79M
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)N/A
Price/book (mrq)4.24
Enterprise value/revenue N/A
Enterprise value/EBITDA N/A

Trading information

Stock price history

Beta (5Y monthly) N/A
52-week change 315.30%
S&P500 52-week change 325.51%
52-week high 332.88
52-week low 38.24
50-day moving average 323.91
200-day moving average 317.67

Share statistics

Avg vol (3-month) 362.72k
Avg vol (10-day) 3155k
Shares outstanding 511.94M
Implied shares outstanding 611.94M
Float 84.88M
% held by insiders 19.24%
% held by institutions 168.87%
Shares short (14 June 2024) 444.6k
Short ratio (14 June 2024) 40.87
Short % of float (14 June 2024) 4N/A
Short % of shares outstanding (14 June 2024) 40.37%
Shares short (prior month 15 May 2024) 431.66k

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 21:18
Last split date 326 Mar 2024

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)31 Mar 2024

Profitability

Profit margin 0.00%
Operating margin (ttm)580.59%

Management effectiveness

Return on assets (ttm)N/A
Return on equity (ttm)N/A

Income statement

Revenue (ttm)-9.6M
Revenue per share (ttm)-1.29
Quarterly revenue growth (yoy)N/A
Gross profit (ttm)N/A
EBITDA -55.23M
Net income avi to common (ttm)-45.88M
Diluted EPS (ttm)-4.51
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)135.31M
Total cash per share (mrq)11.33
Total debt (mrq)25.23M
Total debt/equity (mrq)51.73%
Current ratio (mrq)4.19
Book value per share (mrq)4.09

Cash flow statement

Operating cash flow (ttm)-20.73M
Levered free cash flow (ttm)N/A